COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case- report
Fecha
2020Autor
Faqihi, Fahad
Nasim, Nasir
Noor, Alfateh
Akhtar, Saima
Balshi, Ahmed
Balhamar, Abdullah
Alqahtani, Saleh A.
Memish, Ziad A.
Karakitsos, Dimitrios
Resumen
This is a rare case-report of a young female with systemic lupus erythematosus and end-stage
kidney disease (on maintenance hemodialysis) who was admitted to our intensive care unit due
to life-threatening COVID-19. The patient was diagnosed with a flare of lupus; while being on
maintenance hydroxychloroquine therapy. However, after the administration of steroids she
made an uneventful recovery and was discharged home. In this report, the diagnostic dilemmas
and the therapeutic challenges due to the overlapping clinical, imaging, and laboratory findings
between lupus and COVID-19 pneumonitis are outlined. In conclusion, patients with lupus may
be affected by COVID-19 despite the administration of hydroxychloroquine. The administration
of steroids may have a beneficial effect on mitigating both the flare of SLE and the COVID-19
associated hyperinflammation.
Palabras clave
COVID-19; Systemic Lupus Erythematosus; Acute Respiratory Failure; End-Stage Kidney Disease; Steroid Therapy; HydroxychloroquineEnlace al recurso
https://doi.org/10.1016/j.rmcr.2020.101252Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.